Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's Syndrome: a randomized, double-blind, placebo controlled cross-over study

BACKGROUND: Matrix metalloproteinases (MMPs) are proteolytic enzymes that may contribute to tissue destruction in Sjögren's syndrome (SS). Low-dose doxycycline (LDD) inhibits MMPs. We evaluated the efficacy of LDD for the subjective symptoms in primary SS patients. This was a randomized, double...

Descripción completa

Detalles Bibliográficos
Autores principales: Seitsalo, Hubertus, Niemelä, Raija K, Marinescu-Gava, Magdalena, Vuotila, Tuija, Tjäderhane, Leo, Salo, Tuula
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2235889/
https://www.ncbi.nlm.nih.gov/pubmed/18163919
http://dx.doi.org/10.1186/1477-5751-6-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2235889/
https://www.ncbi.nlm.nih.gov/pubmed/18163919
http://dx.doi.org/10.1186/1477-5751-6-11

Ejemplares similares